在加沙也有痴呆症患者
Bilal Irfan1,2,3,4, Abdallah Abu Shammala5, Nour Alshaer1,6,7
1FAJR Scientific, Houston, TX, USA.
Journal of Alzheimer's disease : JAD
|November 5, 2024
概括
以色列在加沙的军事袭击已经摧毁了痴呆症患者,导致护理系统崩,使他们变得脆弱. 迫切需要采取全球行动来应对这场人道主义危机,并确保所有受影响的个人获得医疗保健.
科学领域:
- 全球健康 全球健康
- 人道主义危机 人道主义危机
- 老年医疗护理 医疗护理
背景情况:
- 以色列在加沙的持续军事袭击严重破坏了基本服务.
- 加沙的痴呆症患者面临着独特的脆弱性,因为他们已经存在疾病并依赖结构化护理.
- 加沙的医疗保健基础设施严重受损,加剧了患者的风险.
研究的目的:
- 为了强调加沙冲突对痴呆症患者的灾难性影响.
- 为了强调对弱势群体的护理系统的崩.
- 呼吁立即进行国际干预和人道主义援助.
主要方法:
- 对事证据和案例研究进行定性分析.
- 审查现有关于加沙人道主义局势的报告.
- 在冲突期间保护弱势群体的伦理和道德检查.
主要成果:
- 痴呆症患者由于流离失所和缺乏医疗支持而经历了极大的脆弱性.
- 严重的药物短缺导致严重的健康恶化和可预防的死亡.
- 对于痴呆症患者至关重要的护理系统已经完全崩.
结论:
- 目前的情况表明,在冲突期间保护弱势群体方面存在严重的道德失败.
- 迫切的全球行动对于解决加沙的人道主义危机至关重要.
- 确保所有人的尊严和获得医疗保健,特别是那些患有痴呆症的人,必须优先考虑.
相关概念视频
Dementia
97
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
97
Alzheimer's Disease: Treatment
165
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
165
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449


